Clinical Study Into the Cosmetic Results of Leukosan Adhesive

Sponsor
Dr. Stephanie Krause (Industry)
Overall Status
Completed
CT.gov ID
NCT02179723
Collaborator
(none)
77
1
2
16
4.8

Study Details

Study Description

Brief Summary

This clinical study aims to assess whether the benefits of using Leukosan Adhesive on trocar incisions are greater or equivalent to those provided by the standard therapy of transcutaneous sutures.

In particular, it tests the long-term cosmetic result after 3 months, the safety and tolerance, as well as the practicality of treatment with Leuksan Adhesive.

An open, randomised, controlled, prospective, single location, clinical study of women of ages between 18 and 60 years within the time span of March 2013 and April 2013.

Condition or Disease Intervention/Treatment Phase
  • Device: Leukosan Adhesive
  • Device: Transcutaneous suture
N/A

Detailed Description

The medical devices compared were EU (European Union) approved market-ready products with relevant designation according to the legal requirements for medical devices and according to Council guideline 93/42/EWG dated 14th July.

Leukosan Adhesive is a sterile, ultra high viscose adhesive for external skin closure. Due to the skin's moisture, this skin adhesive polymerizes within seconds into a flexible film firmly holding the edges of the wound together and protecting the wound itself.

Premilene DSMP 24, 3/8 needle, thread 3/0 denier was used a a comparison. This suture material was the standard suture material used in the study centre.

Study Design

Study Type:
Interventional
Actual Enrollment :
77 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Clinical Study Into the Cosmetic Results of Leukosan Adhesive vs. Transcutaneous Wound Suture With Laparoscopic Trocar Incision
Study Start Date :
Mar 1, 2012
Actual Primary Completion Date :
Apr 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Leukosan Adhesive

Leukosan Adhesive applied to one wound (left or right)

Device: Leukosan Adhesive
Leukosan adhesive applied to one wound

Device: Transcutaneous suture
Transcutaneous suture applied to one wound

Active Comparator: Transcutaneous suture

Transcutaneous suture applied to second wound (left or right)

Device: Leukosan Adhesive
Leukosan adhesive applied to one wound

Device: Transcutaneous suture
Transcutaneous suture applied to one wound

Outcome Measures

Primary Outcome Measures

  1. Patient's satisfaction with cosmetic appearance/result of the wound [3 months post operation]

    The primary outcome was the satisfaction of the patients with the cosmetic result of the wound healing after 3 months. This was measured by a visual analogue scale. In order to validate this result, an additional known wound assessment instrument, an ordinal scaled index, was implemented and the assessment of independent assessors was called on.

Secondary Outcome Measures

  1. The incidence of complication [7-12 days post-operation]

    7-12 days post-operation patients were examined for complications in treatment such as wound dehiscence, maceration, redness, overheating and pain

  2. Intensity of pain [7-12 days post-operation]

    7-12 days post-operation patients were examined for intensity of pain

  3. Investigator's assessment of cosmetic outcome [At 3 months post-operation]

    The Investigator examined patients to assess the cosmetic outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female between 18 and 60

  • Undergone laparoscopic operation with 2 mirror image trocar incisions

  • Willing to attend examination at clinic at 7-12 days and 10-14 weeks

  • Signed agreement by participant

Exclusion Criteria:
  • Length of laparoscopic operation more than 2 hours

  • Hospitalisation due to complications

  • Circumstances leading to difference in trocar incisions

  • Existing scar less than 3 cm from the operation point

  • Diabetic condition melitis HbA1c>9mg/d

  • Known allergy to tissue adhesive

  • Participation in another study within 30 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tagesklinik Altonaer Strasse Hamburg Germany 20357

Sponsors and Collaborators

  • Dr. Stephanie Krause

Investigators

  • Principal Investigator: Olaf Buchweitz, Priv.Doz., Tagesklinik Altonaer Strasse

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Stephanie Krause, Scientific Affairs, Wound Care, BSN Medical GmbH
ClinicalTrials.gov Identifier:
NCT02179723
Other Study ID Numbers:
  • BSNMedicalC09962
  • PV4003
First Posted:
Jul 2, 2014
Last Update Posted:
Jul 2, 2014
Last Verified:
Jun 1, 2014
Keywords provided by Dr. Stephanie Krause, Scientific Affairs, Wound Care, BSN Medical GmbH
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 2, 2014